These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36852365)

  • 1. Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan.
    Ali SM; Raza N; Irfan M; Mohammad MF; Kazmi FH; Fatima Z
    Cureus; 2023 Jan; 15(1):e34216. PubMed ID: 36852365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
    Moiz B; Moatter T; Shaikh U; Adil S; Ali N; Mahar F; Shamsuddin N; Khurshid M
    Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
    Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
    J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
    Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
    Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.
    Agarwal N; Chatterjee K; Coshic P; Borgohain M
    Transfus Apher Sci; 2013 Dec; 49(3):482-4. PubMed ID: 23541414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.
    Kumar R; Gupta S; Kaur A; Gupta M
    Asian J Transfus Sci; 2015; 9(2):199-202. PubMed ID: 26420945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion Transmissible Infections: Maximizing Donor Surveillance.
    Awan SA; Junaid A; Sheikh S
    Cureus; 2018 Dec; 10(12):e3787. PubMed ID: 30868001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid amplification test: Bridging the gap in blood safety & re-evaluation of blood screening for cryptic transfusion-transmitted infection among Indian donors.
    Datta S; Khillan K; Ranjan V; Wattal C
    Indian J Med Res; 2019 Mar; 149(3):389-395. PubMed ID: 31249205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prevalence of Transfusion-transmitted Infections among Blood Donors in Hospital Universiti Sains Malaysia.
    Ramli M; Zulkafli Z; Chambers GK; Zilan RSAR; Edinur HA
    Oman Med J; 2020 Nov; 35(6):e189. PubMed ID: 33110633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan.
    Niazi SK; Bhatti FA; Salamat N; Ghani E; Tayyab M
    Transfusion; 2015 Jul; 55(7):1803-11. PubMed ID: 25648663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ; van Drimmelen HA; Lelie PN
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex real-time RT-PCR assay for transfusion transmitted viruses in sero-negative allogeneic blood donors: an experience from Southern Pakistan.
    Sultan S; Nasir MI; Rafiq S; Baig MA; Akbani S; Irfan SM
    Malays J Pathol; 2017 Aug; 39(2):149-154. PubMed ID: 28866696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting.
    Pandey HC; Varghese M; Rana A; Kumar R; Jain P
    Transfus Med; 2022 Dec; 32(6):492-498. PubMed ID: 36210486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.